Publications
The effect of the foreign body response on drug elution from subdermal delivery systems;
Capuani, S, Hernandez, N, Campa-Carranza, JN, Di Trani, N, Yoshikawa, T, Farina, M, Joubert, AL, Caffey, CA, Simeone, A, Cho, SW, Stayton, PS, Chua, CYX & Grattoni, A 2025, , Biomaterials, vol. 317, 123110, pp. 123110. https://doi.org/10.1016/j.biomaterials.2025.123110
Contrastive learning in brain imaging;
Xu, X & Wong, STC 2025, , Computerized Medical Imaging and Graphics, vol. 121, 102500. https://doi.org/10.1016/j.compmedimag.2025.102500
Transplantation for Peri-Hilar and Intrahepatic Cholangiocarcinoma With mTOR Immunosuppression;
Semaan, S, Connor, AA, Saharia, A, Kodali, S, Elaileh, A, Patel, K, Soliman, N, Basra, T, Victor, DW, Simon, CJ, Cheah, YL, Hobeika, MJ, Mobley, CM, Dhingra, S, Schwartz, MR, Maqsood, A, Heyne, K, Abdelrahim, M, Li, XC, Javle, M, Vauthey, JN, Gaber, AO & Ghobrial, RM 2025, , Transplantation Proceedings, vol. 57, no. 2, pp. 255-263. https://doi.org/10.1016/j.transproceed.2025.02.001
HER2-positive breast cancer in patients with BRCA1/2 pathogenic variants: Case series and literature review;
Munnangi, P, Niravath, PA, Chang, JC & Sun, K 2025, , Current Problems in Cancer: Case Reports, vol. 17, 100335. https://doi.org/10.1016/j.cpccr.2024.100335
Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar Cholangiocarcinoma;
Soliman, N, Connor, AA, Saharia, A, Kodali, S, Elaileh, A, Patel, K, Semaan, S, Basra, T, Victor, DW, Simon, CJ, Cheah, YL, Hobeika, MJ, Mobley, CM, Divatia, M, Dhingra, S, Schwartz, M, Maqsood, A, Heyne, K, Abdelrahim, M, Javle, M, Vauthey, JN, Gaber, AO & Ghobrial, RM 2025, , Transplantation Direct, vol. 11, no. 3, e1760, pp. e1760. https://doi.org/10.1097/TXD.0000000000001760
Rational Design of Safer Inorganic Nanoparticles via Mechanistic Modeling-informed Machine Learning;
Dogra, P, Cave, J, Christiono, A, Schiavone, C, Pownall, H, Cristini, V, Staquicini, D, Brinker, C, Campen, M, Wang, Z, Nguyen, HV & Noureddine, A 2025, , Research square. https://doi.org/10.21203/rs.3.rs-5960303/v1
Dual nuclear receptor 4A1 (NR4A1/NR4A2) ligands inhibit glioblastoma growth and target TWIST1;
Upadhyay, S, Lee, M, Zhang, L, Oany, AR, Mikheeva, SA, Mikheev, AM, Rostomily, RC & Safe, S 2025, , Molecular Pharmacology, vol. 107, no. 2, 100009. https://doi.org/10.1016/j.molpha.2024.100009
Transplant oncology: keeping the patient's perspective in mind;
Bachini, M & Ghobrial, RM 2025, , Current opinion in organ transplantation, vol. 30, no. 1, pp. 1-2. https://doi.org/10.1097/MOT.0000000000001186
Sorafenib as Adjuvant Therapy Post-Liver Transplant: A Single-center Experience;
Hassanain, H, Connor, AA, Brombosz, EW, Patel, K, Elaileh, A, Basra, T, Kodali, S, Victor, DW, Simon, CJ, Cheah, YL, Hobeika, MJ, Mobley, CM, Saharia, A, Dhingra, S, Schwartz, M, Maqsood, A, Heyne, K, Kaseb, AO, Vauthey, JN, Gaber, AO, Abdelrahim, M & Ghobrial, RM 2025, , Transplantation Direct, vol. 11, no. 2, pp. e1746. https://doi.org/10.1097/TXD.0000000000001746
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study;
Kudo, M, Ren, Z, Guo, Y, Han, G, Lin, H, Zheng, J, Ogasawara, S, Kim, JH, Zhao, H, Li, C, Madoff, DC, Ghobrial, RM, Kawaoka, T, Gerolami, R, Ikeda, M, Kumada, H, El-Khoueiry, AB, Vogel, A, Peng, X, Mody, K, Dutcus, C, Dubrovsky, L, Siegel, AB, Finn, RS & Llovet, JM 2025, , The Lancet, vol. 405, no. 10474, pp. 203-215. https://doi.org/10.1016/S0140-6736(24)02575-3